- Comprar cripto
- Mercados
- Contratos
- Spot
- Copy trading
WE-Launch
US Biopharmaceutical Company Liminatus Pharma Plans to Raise $500 Million to Invest in BNB
BlockBeats News, July 28th, According to a report by businessinsider, Clinical-stage biopharmaceutical company Liminatus Pharma, Inc. (NASDAQ: LIMN) today announced plans to strategically expand into the cryptocurrency and blockchain space.
The company plans to establish a subsidiary named "American BNB Strategy" to lead its digital asset investment and management plan. Through this platform, Liminatus plans to gradually raise and deploy up to $500 million in funds, with the goal of strategically long-term investing in BNB.
Liminatus emphasized that while the company remains fully committed to its core business - advancing cancer treatments and pancreatic cancer diagnostic technologies, expanding into the digital asset space is seen as a necessary step to support long-term growth and enhance shareholder value.
Liminatus is a clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer patients. The company is advancing a series of novel therapies targeting cancer antigens and tumor-specific immune responses.
También te puede gustar
Ganadores
Últimas noticias cripto
El Banco Central de Rusia ha confirmado que puede relajar las reglas de regulación de criptomonedas.
OCDE: Espera que la Reserva Federal "baje gradualmente" la tasa de interés clave a 3,25% a 3,5%
Asset Management Giant Tidal Investments adquiere aproximadamente 60 millones de dólares en acciones estratégicas
Wintermute: La estructura del mercado está mejorando, los tokens convencionales ya no son frágiles
Una ballena que se mantiene fuerte en las redes de 'cortometrajes de mierda' $6.417 millones en ganancias no realizadas, la ganancia total de la cuenta supera los $78.86 millones
Atención al cliente：@weikecs
Cooperación comercial：@weikecs
Trading cuantitativo y MM：[email protected]
Servicios VIP：[email protected]
App